8 active warrant series covering 19,935,966 shares (~14.2% potential dilution); nearest expiry 2026-10-09.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.50 | Oct 9, 2026 9d | 1.5M | ITM | 1.1% | C$766K | Auto |
| warrant | $0.40 | Oct 24, 2026 24d | 4.6M | ITM | 3.3% | C$1.8M | Auto |
| warrant | $0.40 | Nov 15, 2026 46d | 4.3M | ITM | 3.1% | C$1.7M | Auto |
| warrant | $0.40 | Nov 22, 2026 53d | 600K | ITM | 0.4% | C$240K | Auto |
| warrant | $0.45 | Jun 10, 2027 253d | 53K | ITM | 0.0% | C$24K | Auto |
| finder | $0.45 | Jun 10, 2027 253d | 1.1M | ITM | 0.8% | C$480K | Auto |
| warrant | $0.55 | Jun 10, 2027 253d | 6.8M | ITM | 4.8% | C$3.7M | Auto |
| warrant | $1.10 | Feb 19, 2028 507d | 1.0M | ITM | 0.7% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 5,900,000 shares (~4.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.33 | Feb 13, 2030 1232d | 450K | ITM | 0.3% | C$149K | Auto |
| option | $0.49 | Mar 8, 2030 1255d | 250K | ITM | 0.2% | C$123K | Auto |
| option | $1.18 | Dec 23, 2030 1545d | 4.2M | ITM | 3.0% | C$5.0M | Auto |
| option | $1.53 | Apr 29, 2031 1672d | 800K | OTM | 0.6% | C$1.2M | Auto |
| option | $1.57 | May 14, 2031 1687d | 200K | OTM | 0.1% | C$314K | Auto |
139,902,305 shares outstanding, plus 19,935,966 from warrants and 5,900,000 from options — a fully diluted 165,738,271 shares, or ~18.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
8 active warrant series covering 19,935,966 shares (~14.2% potential dilution); nearest expiry 2026-10-09.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.50 | Oct 9, 2026 9d | 1.5M | ITM | 1.1% | C$766K | Auto |
| warrant | $0.40 | Oct 24, 2026 24d | 4.6M | ITM | 3.3% | C$1.8M | Auto |
| warrant | $0.40 | Nov 15, 2026 46d | 4.3M | ITM | 3.1% | C$1.7M | Auto |
| warrant | $0.40 | Nov 22, 2026 53d | 600K | ITM | 0.4% | C$240K | Auto |
| warrant | $0.45 | Jun 10, 2027 253d | 53K | ITM | 0.0% | C$24K | Auto |
| finder | $0.45 | Jun 10, 2027 253d | 1.1M | ITM | 0.8% | C$480K | Auto |
| warrant | $0.55 | Jun 10, 2027 253d | 6.8M | ITM | 4.8% | C$3.7M | Auto |
| warrant | $1.10 | Feb 19, 2028 507d | 1.0M | ITM | 0.7% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 5,900,000 shares (~4.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.33 | Feb 13, 2030 1232d | 450K | ITM | 0.3% | C$149K | Auto |
| option | $0.49 | Mar 8, 2030 1255d | 250K | ITM | 0.2% | C$123K | Auto |
| option | $1.18 | Dec 23, 2030 1545d | 4.2M | ITM | 3.0% | C$5.0M | Auto |
| option | $1.53 | Apr 29, 2031 1672d | 800K | OTM | 0.6% | C$1.2M | Auto |
| option | $1.57 | May 14, 2031 1687d | 200K | OTM | 0.1% | C$314K | Auto |
139,902,305 shares outstanding, plus 19,935,966 from warrants and 5,900,000 from options — a fully diluted 165,738,271 shares, or ~18.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
